“Minimal Residual Disease Monitoring: The New Standard for Treatment Evaluation of Haematological Malignancies?”. Swiss Medical Weekly, vol. 144, no. 0304, Jan. 2014, p. w13907, https://doi.org/10.4414/smw.2014.13907.